Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The future role of inotropic drugs.

Literature DB >> 3569109

The future role of inotropic drugs.

Abstract

Inotropic drugs have not, as yet, been shown in double-blind, randomised and placebo-controlled trials to be of value in the treatment of heart failure. There are theoretical reasons why inotropic drugs may initiate arrhythmias, worsen ischaemia and possibly even increase mortality.

Entities: Disease

Mesh：

Substances：

Year: 1986 PMID： 3569109 DOI： 10.2165/00003495-198600325-00004

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

24 in total

Review 1. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.

Authors: M Packer
Journal: J Am Coll Cardiol Date: 1983-11 Impact factor: 24.094

2. Digitalis-associated cardiac mortality after myocardial infarction.

Authors: A J Moss; H T Davis; D L Conard; J J DeCamilla; C L Odoroff
Journal: Circulation Date: 1981-12 Impact factor: 29.690

3. Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial.

Authors: R Byington; S Goldstein
Journal: J Am Coll Cardiol Date: 1985-11 Impact factor: 24.094

4. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors: S M Dobbs; W I Kenyon; R J Dobbs
Journal: Br Med J Date: 1977-03-19

5. Amrinone in the treatment of chronic cardiac failure.

Authors: M J Likoff; K T Weber; V Andrews; J S Janicki; M S Sutton; H Wilson; M L Rocci
Journal: J Am Coll Cardiol Date: 1984-05 Impact factor: 24.094

6. Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.

Authors: J E Muller; Z G Turi; P H Stone; R E Rude; D S Raabe; A S Jaffe; H K Gold; N Gustafson; W K Poole; E Passamani; T W Smith; E Braunwald
Journal: N Engl J Med Date: 1986-01-30 Impact factor: 91.245

7. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.

Authors: J R Dawson; R Canepa-Anson; P Kuan; S R Reuben; P A Poole-Wilson; G C Sutton
Journal: Br Heart J Date: 1983-09

8. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Authors: J Bayliss; M S Norell; R Canepa-Anson; C Reid; P Poole-Wilson; G Sutton
Journal: Br Med J (Clin Res Ed) Date: 1985-06-22

9. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors: D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal: Br Heart J Date: 1985-02

10. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

Authors: J L Fleg; S H Gottlieb; E G Lakatta
Journal: Am J Med Date: 1982-08 Impact factor: 4.965

1 in total

Review 1. Long-term studies with xamoterol in heart failure.

Authors: D G Waller
Journal: Br J Clin Pharmacol Date: 1989 Impact factor: 4.335

1 in total